Pages

Monday, April 8, 2013

State of Washington Legislative 2013 Session Update


No. 1141 2013 Legislative Session
Update
March 15, marked the last day to consider legislative bills
in the house of origin. The Board reviewed bills including one
for a medication return and reuse program, as well as proposed
changes to the Legend Drug Act and Uniform Controlled Substances
Act. Following are bills that are still alive but not yet
passed into law. The regular legislative session ends April 28.
The Board will update readers then, via listserv, on new laws.
More details and bill language are on the Washington State
Legislature’s Bill Information Web page.
♦♦ SHB 1182 – The bill adds pharmacists to the Legend
Drug Act to specify that licensed pharmacists may prescribe
legend drugs within the scope of their practice
act/as authorized under a collaborative drug therapy
agreement.
♦♦ SHB 1382 – Under the bill, practitioners, pharmacists,
medical facilities, drug manufacturers, and drug wholesalers
could give pharmacies prescription drugs and
supplies to redistribute, without being paid, to people
who meet certain criteria. Pharmacies, pharmacists,
and prescribing practitioners that elect to dispense
donated prescription drugs and supplies would give
priority to uninsured people who are at or below 200%
of the federal poverty level (S SB 5148 – Allowing for
redistribution of medications under certain conditions).
♦♦ HB 1609 – The bill changes the Washington State Board
of Pharmacy’s name to the Pharmacy Quality Assurance
Commission. It doubles the number of members to 10
pharmacists, four public members, and one pharmacist
technician.

HB 1800 – The bill adds exceptions to term “manufacturing”
for the (1) compounding of products in anticipation
of an order of a practitioner to administer to patients
under his or her direct supervision; (2) repackaging of
commercially available medication in small, reasonable
quantities for practitioners to use for office use;
(3) distribution of compounded drugs to other entities
under common ownership of the facility in which the
compounding takes place; (4) delivery of compounded
products that are dispensed pursuant to a valid prescription
to alternate delivery locations when requested by
the patient, the prescriber to administer to the patient,
or another pharmacy to dispense to the patient; or (5)
distribution of a compounded drug to other licensed
persons or commercial entities for resale or distribution,
without specific product item approval by the Board.
Compounded products or products prepared for patient
administration or distribution to a practitioner for patient
use must meet the oral product and parenteral product
standards of the United States Pharmacopeia.
♦♦ EHB 1808 – The bill requires the store manager or
employee in a retail store with a pharmacy license to
notify law enforcement upon finding one ounce or less
of marijuana mistakenly left in the store. The bill defines
“proper disposal” and requires the Board to adopt rules
in conjunction with law enforcement.
♦♦ ESB 5104 – The bill places epinephrine autoinjectors
in schools.
♦♦ SB 5149 – The bill modifies standard sentencing provisions
about a robbery of a pharmacy.
♦♦ 2S SB 5213 – Requires contracts with managed care
plans to include a requirement that any patient with
five or more prescriptions be placed in a comprehensive
medication management process with the primary care
provider or state-licensed pharmacist to verify all the
prescriptions are medically appropriate and to review
for drug interactions and opportunities to reduce the
number of prescriptions.
♦♦ S SB 5416 – The bill permits original prescriptions or
prescription refills for CS (including Schedule II) to be
electronically communicated between the authorized
practitioner and a pharmacy. Companion bill: SHB
1155.
♦♦ S SB 5459 – The bill permits pharmacists to dispense
up to a 90-day supply of a drug, other than a CS, with
a valid prescription that specifies the initial quantity
of less than a 90-day supply followed by refills under
specific conditions. Those include the patient having
completed an initial 30-day supply of the drug, or having
been previously dispensed the same medication in a 90-day supply.

Source found here

No comments:

Post a Comment